Chronic fatigue syndrome and an illness-focused approach to care: controversy, morality and paradox.
chronic fatigue syndrome
fatigue
integrated care
mind-body
philosophy
Journal
Medical humanities
ISSN: 1473-4265
Titre abrégé: Med Humanit
Pays: United States
ID NLM: 100959585
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
accepted:
10
04
2019
pubmed:
20
6
2019
medline:
15
1
2020
entrez:
20
6
2019
Statut:
ppublish
Résumé
Contemporary medicine distinguishes between illness and disease. Illness refers to a person's subjective experience of symptoms; disease refers to objective bodily pathology. For many illnesses, medicine has made great progress in finding and treating associated disease. However, not all illnesses are successfully relieved by treating the disease. In some such cases, the patient's suffering can only be reduced by treatment that is focused on the illness itself. Chronic disabling fatigue is a common symptom of illness, for which disease-focused treatment is often not effective, but for which illness-focused treatments (psychological or behavioural) often are. In this article, we explore a controversy surrounding illness-focused treatments for fatigue. We do this by contrasting their acceptance by people whose fatigue is associated with a disease (using the example of cancer-related fatigue) with their controversial rejection by some people whose fatigue is not associated with an established disease (chronic fatigue syndrome or CFS, sometimes called ME (myalgic encephalomyelitis)). In order to understand this difference in acceptability we consider the differing moral connotations of illness and disease and then go on to examine the limitations of the concepts of illness and disease themselves. We conclude that a general acceptance of illness-focused treatments by all who might benefit from them will require a major long-term change in thinking about illness, but that improvements to the care of individual patients can be made today.
Identifiants
pubmed: 31213482
pii: medhum-2018-011598
doi: 10.1136/medhum-2018-011598
pmc: PMC6699605
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
183-187Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0200434
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: Dr Sharpe reports: I have published on CFS and its treatment. I was an author on the PACE trial of treatments for CFS cited in this article.
Références
Eur J Cancer. 2002 Jan;38(1):27-43
pubmed: 11750837
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006953
pubmed: 19160308
Phys Ther. 2010 Oct;90(10):1413-25
pubmed: 20651011
Lancet. 2011 Mar 5;377(9768):823-36
pubmed: 21334061
Soc Sci Med. 2011 Sep;73(6):793-800
pubmed: 21868144
Psychosom Med. 1990 Nov-Dec;52(6):653-72
pubmed: 2287704
BMJ Open. 2014 Feb 07;4(2):e003973
pubmed: 24508851
Lancet Psychiatry. 2016 Feb;3(2):e7-8
pubmed: 26795759
Disabil Rehabil. 2018 Jun 21;:1-10
pubmed: 29929450
Cult Med Psychiatry. 1977 Apr;1(1):9-23
pubmed: 756356
Ann Intern Med. 1994 Dec 15;121(12):953-9
pubmed: 7978722
Science. 1977 Apr 8;196(4286):129-36
pubmed: 847460